Equities

Roquefort Therapeutics PLC

ROQ:LSE

Roquefort Therapeutics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)5.60
  • Today's Change0.75 / 15.46%
  • Shares traded6.49m
  • 1 Year change-20.00%
  • Beta0.0324
Data delayed at least 20 minutes, as of Oct 31 2024 16:28 BST.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Dec 31 20212021
ASSETS
Cash And Short Term Investments0.90
Total Receivables, Net2.18
Total Inventory--
Prepaid expenses--
Other current assets, total--
Total current assets3.08
Property, plant & equipment, net--
Goodwill, net--
Intangibles, net1.48
Long term investments--
Note receivable - long term--
Other long term assets--
Total assets4.56
LIABILITIES
Accounts payable0.20
Accrued expenses--
Notes payable/short-term debt0
Current portion long-term debt/capital leases--
Other current liabilities, total--
Total current liabilities0.20
Total long term debt0
Total debt0
Deferred income tax0.28
Minority interest--
Other liabilities, total--
Total liabilities0.48
SHAREHOLDERS EQUITY
Common stock0.72
Additional paid-in capital3.91
Retained earnings (accumulated deficit)(0.55)
Treasury stock - common--
Unrealized gain (loss)--
Other equity, total0.00
Total equity4.08
Total liabilities & shareholders' equity4.56
Total common shares outstanding72
Treasury shares - common primary issue0
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.